Search

Search Constraints

You searched for: Author/Creator Okamoto, Masataka

Search Results

1. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease. Issue 2 (February 2016)

2. Epstein‐Barr virus (EBV)‐positive diffuse large B‐cell lymphoma arising in patient with a history of EBV‐positive mucocutaneous ulcer and EBV‐positive nodal polymorphous B‐lymphoproliferative disorder. Issue 1 (19th November 2018)

3. ETV6‐LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98‐HOXA9. Issue 3 (6th November 2015)

4. Gene expression profiling of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways. Issue 5 (9th April 2014)

5. Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma. Issue 4 (April 2015)

6. Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma. Issue 4 (April 2015)

7. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan. (7th May 2015)

8. Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma. Issue 11 (7th October 2015)

9. Reappraisal of Epstein–Barr virus (EBV) in diffuse large B‐cell lymphoma (DLBCL): comparative analysis between EBV‐positive and EBV‐negative DLBCL with EBV‐positive bystander cells. Issue 1 (12th April 2017)

10. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Issue 4 (April 2020)